Hafler DA - Search Results

1

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Viglietta V, et al. Among authors: hafler da. J Exp Med. 2004 Apr 5;199(7):971-9. doi: 10.1084/jem.20031579. J Exp Med. 2004. PMID: 15067033 Free PMC article.

2

GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.

Viglietta V, Kent SC, Orban T, Hafler DA. Viglietta V, et al. Among authors: hafler da. J Clin Invest. 2002 Apr;109(7):895-903. doi: 10.1172/JCI14114. J Clin Invest. 2002. PMID: 11927616 Free PMC article.

3

Inhibition of human CD4(+)CD25(+high) regulatory T cell function.

Baecher-Allan C, Viglietta V, Hafler DA. Baecher-Allan C, et al. Among authors: hafler da. J Immunol. 2002 Dec 1;169(11):6210-7. doi: 10.4049/jimmunol.169.11.6210. J Immunol. 2002. PMID: 12444126

4

CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls.

Oliveira EM, Bar-Or A, Waliszewska AI, Cai G, Anderson DE, Krieger JI, Hafler DA. Oliveira EM, et al. Among authors: hafler da. J Autoimmun. 2003 Feb;20(1):71-81. doi: 10.1016/s0896-8411(02)00106-3. J Autoimmun. 2003. PMID: 12604314

5

Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.

O'Connor KC, Chitnis T, Griffin DE, Piyasirisilp S, Bar-Or A, Khoury S, Wucherpfennig KW, Hafler DA. O'Connor KC, et al. Among authors: hafler da. J Neuroimmunol. 2003 Mar;136(1-2):140-8. doi: 10.1016/s0165-5728(03)00002-x. J Neuroimmunol. 2003. PMID: 12620653

6

CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo.

Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. Baecher-Allan C, et al. Among authors: hafler da. Novartis Found Symp. 2003;252:67-88; discussion 88-91, 106-14. doi: 10.1002/0470871628.ch6. Novartis Found Symp. 2003. PMID: 14609213

7

Human CD4+CD25+ regulatory T cells.

Baecher-Allan C, Viglietta V, Hafler DA. Baecher-Allan C, et al. Among authors: hafler da. Semin Immunol. 2004 Apr;16(2):89-98. doi: 10.1016/j.smim.2003.12.005. Semin Immunol. 2004. PMID: 15036232 Review.

8

Cross-reactive TCR responses to self antigens presented by different MHC class II molecules.

Mycko MP, Waldner H, Anderson DE, Bourcier KD, Wucherpfennig KW, Kuchroo VK, Hafler DA. Mycko MP, et al. Among authors: hafler da. J Immunol. 2004 Aug 1;173(3):1689-98. doi: 10.4049/jimmunol.173.3.1689. J Immunol. 2004. PMID: 15265898

9

Suppressor T cells in human diseases.

Baecher-Allan C, Hafler DA. Baecher-Allan C, et al. Among authors: hafler da. J Exp Med. 2004 Aug 2;200(3):273-6. doi: 10.1084/jem.20040812. Epub 2004 Jul 26. J Exp Med. 2004. PMID: 15280423 Free PMC article.

10

PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells.

Cai G, Karni A, Oliveira EM, Weiner HL, Hafler DA, Freeman GJ. Cai G, et al. Among authors: hafler da. Cell Immunol. 2004 Aug;230(2):89-98. doi: 10.1016/j.cellimm.2004.09.004. Cell Immunol. 2004. PMID: 15598424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters